NCI scientists identified adult patients with non-Hodgkin’s lymphoma likely to be cured by chemotherapy
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Monoclonal antibody rituximab (Rituxan) approved by the FDA to treat patients with non-Hodgkin lymphoma
On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…